BYURO PEREVODOV MEDIFARM, OOO, Moscow

Accounting reports

Previously

Name	BYURO PEREVODOV MEDIFARM, OOO
INN	9715267369
KPP	771501001
OGRN	1167746686722
OKPO	03627292
Address	127427, G.moskva, ul. Bol'shaya Marfinskaya, d. D. 1, of. KV. 5
Phone	+7 (929) 654-99-34

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities BYURO PEREVODOV MEDIFARM, OOO according to EGRUL
74.30	Core activity	Translation and interpretation activities

Registration information

Registration date	21.07.2016

Description

BYURO PEREVODOV MEDIFARM, OOO (Moscow; INN 9715267369) was registered on 21 Jul 2016. The company's authorized capital as of July 1, 2012 was 10000 rub.

Principal activities of BYURO PEREVODOV MEDIFARM, OOO: translation and interpretation activities (74.30).

Industry

74 - Activities of professional, scientific and technical products
- 74.3 - Activities for translation and interpretation
  - 74.30 - Translation and interpretation activities

Economic indicators

2023

Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2023 by 40.28% to 52.17 million RUB from 37.19 million RUB over 2022, the company informed.

Revenue increased in the accounting period by 39.63% to 57.01 million RUB from 40.83 million RUB over 2022.

2022

Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2022 by 13.44% to 37.19 million RUB from 32.78 million RUB over 2021, the company informed.

Revenue increased in the accounting period by 13.22% to 40.83 million RUB from 36.06 million RUB over 2021.

2021

Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO dropped in 2021 by 15.64% to 32.78 million RUB from 38.86 million RUB over the same period in 2020, the company informed.

Revenue decreased in the accounting period by 14.00% to 36.06 million RUB from 41.94 million RUB in 2020.

2020

Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2020 1.91 times to 38.86 million RUB from 20.34 million RUB over 2019, the company informed.

Revenue increased in the accounting period 1.89 times to 41.94 million RUB from 22.15 million RUB over 2019.

2019

Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO over 2019 was the same as in 2018 reaching 20.34 million RUB, the company informed.

Revenue decreased in the accounting period by 0.69% to 22.15 million RUB from 22.30 million RUB in 2018.

2018

Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2018 1.76 times to 20.35 million RUB from 11.59 million RUB over 2017, the company informed.

Revenue increased in the accounting period 1.74 times to 22.30 million RUB from 12.82 million RUB over 2017; cost of goods sold grew by 46.95% to 770.00 thousand RUB from 524.00 thousand RUB; sales profit went up 1.75 times to 21.53 million RUB from 12.30 million RUB.

2017

Net profit (RAS) of BYURO PEREVODOV MEDIFARM, OOO grew over 2017 3.54 times to 11.59 million RUB from 3.28 million RUB over 2016, the company informed.

Revenue increased in the accounting period 3.56 times to 12.82 million RUB from 3.60 million RUB over 2016; cost of goods sold grew 4.48 times to 524.00 thousand RUB from 117.00 thousand RUB; sales profit went up 3.53 times to 12.30 million RUB from 3.48 million RUB.

2016

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 335 808

Reports

17 430 600

Rrocessed requests

Extract from EGRUL:

Today, 3:50 PM

Accounting reports:

Today, 3:48 PM